Researchers conducted a systematic review and meta-analysis that compared outcomes of 4 antiviral agents for the treatment of patients with seasonal influenza.
A large, retrospective study compared the asthma control effectiveness of once-daily fluticasone furoate/vilanterol vs twice-daily budesonide/formoterol.
An NIH review explored whether Bruton tyrosine kinase inhibitors decreased oxygen requirements and hospitalizations for patients with SARS-CoV-2.
A British community cohort study reexamined statistics on hospitalization for COVID-19 among individuals with asthma, COPD, ILD, lung cancer, and other airway diseases.
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine.
A new algorithm offers guidance on when to start and stop noninvasive respiratory therapies for COVID-19.
Sickle cell disease is associated with a fourfold increased risk for COVID-19-related hospitalization and a more than twofold increased risk for COVID-19-related death.
Researchers compared clinical outcomes of single vs double antipseudomonal antibiotics used to treat pulmonary exacerbations in patients with cystic fibrosis.
Researchers assessed long-term outcomes of multidrug-resistant Enterobacterales colonization and infections among solid organ transplant recipients.
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
